Maciej Smialek

Mr. Maciej Smialek

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

21 August 2018 in Oncotarget
Verified
Journal Article
Open access
PDF file
DJDamian Mikolaj Janecki
Damian Mikolaj Janecki
MSMarcin Piotr Sajek
Marcin Piotr Sajek
MSMaciej Smialek
Maciej Smialek
MKMaciej Kotecki
Maciej Kotecki
BGBarbara Ginter-Matuszewska
Barbara Ginter-Matuszewska
Jadwiga JaruzelskaJadwiga Jaruzelska
Jadwiga Jaruzelska
SPIN1 is a proto-oncogene and SPIN3 is a tumor suppressor in human seminoma SPIN1 is a proto-oncogene and SPIN3 is a tumor suppressor in human seminoma

3 January 2021 in Cancers
Verified
Journal Article
Open access
PDF file
MSMaciej Smialek
Maciej Smialek
EIErkut Ilaslan
Erkut Ilaslan
MSMarcin Piotr Sajek
Marcin Piotr Sajek
Jadwiga JaruzelskaJadwiga Jaruzelska
Jadwiga Jaruzelska
Until recently, post-transcriptional gene regulation (PTGR), in contrast to transcriptional regulation, was not extensively explored in cancer, even though it seems to be highly important. PUM proteins are well described in the PTGR of several organisms and contain the PUF RNA-binding domain that recognizes the UGUANAUA motif, located mostly in the 3′ untranslated region (3′UTR) of target mRNAs. Depending on the protein cofactors recruited by PUM proteins, target mRNAs are directed towards translation, repression, activation, degradation, or specific localization. Abnormal profiles of PUM expression have been shown in several types of cancer, in some of them being different for PUM1 and PUM2. This review summarizes the dysregulation of PUM1 and PUM2 expression in several cancer tissues. It also describes the regulatory mechanisms behind the activity of PUMs, including cooperation with microRNA and non-coding RNA machineries, as well as the alternative polyadenylation pathway. It also emphasizes the importance of future studies to gain a more complete picture of the role of PUM proteins in different types of cancer. Such studies may result in identification of novel targets for future cancer therapies.

29 September 2018 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
MSMarcin Sajek
Marcin Sajek
DJDamian Mikolaj Janecki
Damian Mikolaj Janecki
MSMaciej Smialek
Maciej Smialek
BGBarbara Ginter-Matuszewska
Barbara Ginter-Matuszewska
ASAnna Spik
Anna Spik
Jadwiga JaruzelskaJadwiga Jaruzelska
Jadwiga Jaruzelska

Verified
Journal Article
Open access
PDF file
EIErkut Ilaslan
Erkut Ilaslan
KKKrystyna Kwiatkowska
Krystyna Kwiatkowska
MSMaciej Smialek
Maciej Smialek
MSMarcin Piotr Sajek
Marcin Piotr Sajek
ŻLŻaneta Lemańska
Żaneta Lemańska
KKKamila Kusz-Zamelczyk
Kamila Kusz-Zamelczyk
Nanos RNA-binding proteins are critical factors of germline development throughout the animal kingdom and their dysfunction causes infertility. During evolution, mammalian Nanos paralogues adopted divergent roles in germ cell biology. However, the molecular basis behind this divergence, such as their target mRNAs, remains poorly understood. Our RNA-sequencing analysis in a human primordial germ cell model-TCam-2 cell line revealed distinct pools of genes involved in the cell cycle process downregulated upon NANOS1 and NANOS3 overexpression. We show that NANOS1 and NANOS3 proteins influence different stages of the cell cycle. Namely, NANOS1 is involved in the G1/S and NANOS3 in the G2/M phase transition. Many of their cell cycle targets are known infertility and cancer-germ cell genes. Moreover, NANOS3 in complex with RNA-binding protein PUM1 causes 3′UTR-mediated repression of FOXM1 mRNA encoding a transcription factor crucial for G2/M phase transition. Interestingly, while NANOS3 and PUM1 act as post-transcriptional repressors of FOXM1, FOXM1 potentially acts as a transcriptional activator of NANOS3, PUM1, and itself. Finally, by utilizing publicly available RNA-sequencing datasets, we show that the balance between FOXM1-NANOS3 and FOXM1-PUM1 expression levels is disrupted in testis cancer, suggesting a potential role in this disease.

16 April 2020 in Cells
Verified
Journal Article
Open access
PDF file
MSMaciej Smialek
Maciej Smialek
EIErkut Ilaslan
Erkut Ilaslan
MSMarcin Piotr Sajek
Marcin Piotr Sajek
ASAleksandra Swiercz
Aleksandra Swiercz
DJDamian Mikolaj Janecki
Damian Mikolaj Janecki
Jadwiga JaruzelskaJadwiga Jaruzelska
Jadwiga Jaruzelska
Mammalian Pumilio (PUM) proteins are sequence-specific, RNA-binding proteins (RBPs) with wide-ranging roles. They are involved in germ cell development, which has functional implications in development and fertility. Although human PUM1 and PUM2 are closely related to each other and recognize the same RNA binding motif, there is some evidence for functional diversity. To address that problem, first we used RIP-Seq and RNA-Seq approaches, and identified mRNA pools regulated by PUM1 and PUM2 proteins in the TCam-2 cell line, a human male germ cell model. Second, applying global mass spectrometry-based profiling, we identified distinct PUM1- and PUM2-interacting putative protein cofactors, most of them involved in RNA processing. Third, combinatorial analysis of RIP and RNA-Seq, mass spectrometry, and RNA motif enrichment analysis revealed that PUM1 and PUM2 form partially varied RNP-regulatory networks (RNA regulons), which indicate different roles in human reproduction and testicular tumorigenesis. Altogether, this work proposes that protein paralogues with very similar and evolutionary highly conserved functional domains may play divergent roles in the cell by combining with different sets of protein cofactors. Our findings highlight the versatility of PUM paralogue-based post-transcriptional regulation, offering insight into the mechanisms underlying their diverse biological roles and diseases resulting from their dysfunction.